Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC
To evaluate the effect of novel DNA demethylating agents in the treatment of metastatic TNBC
Breast Neoplasm
DRUG: Decitabine|DRUG: Carboplatin
Overall response rate, Partial response (PR) + complete response (CR) rate, At the end of Cycle 6 (each cycle is 21 days)
To evaluate the effect of novel DNA demethylating agents in the treatment of metastatic TNBC